Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Director departure
Appointed CFO
Inv. presentation
Quarterly results
|
|
Cytosorbents Corp (CTSO)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 09/27/2023 |
8-K
| Quarterly results |
| 08/15/2023 |
3
| D'Amico Alex (CFO) has filed a Form 3 on Cytosorbents Corp |
| 08/11/2023 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 08/08/2023 |
4
| BATOR MICHAEL G. (Director) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Bought 1,000 shares
@ $3.23, valued at
$3.2k
Bought 1,000 shares
@ $3.2, valued at
$3.2k
Bought 1,000 shares
@ $3.15, valued at
$3.2k
|
|
| 08/01/2023 |
8-K
| Quarterly results |
| 08/01/2023 |
10-Q
| Quarterly Report for the period ended June 30, 2023 |
| 07/19/2023 |
8-K
| Quarterly results |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/11/2023 |
8-K
| Quarterly results |
| 07/07/2023 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 06/07/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/12/2023 |
4
| BLOCH KATHLEEN P. (Interim CFO) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Bought 5,000 shares
@ $3.0596, valued at
$15.3k
Bought 2,000 shares
@ $3.125, valued at
$6.3k
Bought 3,000 shares
@ $3.1699, valued at
$9.5k
|
|
| 05/02/2023 |
8-K
| Quarterly results |
| 05/02/2023 |
10-Q
| Quarterly Report for the period ended March 31, 2023 |
| 04/26/2023 |
8-K
| Quarterly results |
| 04/21/2023 |
ARS
| Form ARS - Annual Report to Security Holders: |
| 04/21/2023 |
DEFA14A
| Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material: |
| 04/21/2023 |
DEF 14A
| Form DEF 14A - Other definitive proxy statements: |
| 04/20/2023 |
8-K
| Quarterly results |
| 04/06/2023 |
8-K
| Entry into a Material Definitive Agreement, Departure of Directors or Certain Officers; Election of Directors; Appointment of... |
| 04/05/2023 |
4
| Capponi Vincent (See Remarks) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Exercised 10,000 options to buy
@ $2.875, valued at
$28.8k
|
|
| 04/05/2023 |
4
| Chan Phillip P. (CEO) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Exercised 30,500 options to buy
@ $2.875, valued at
$87.7k
|
|
| 03/09/2023 |
8-K
| Results of Operations and Financial Condition, Financial Statements and Exhibits Interactive Data |
| 03/09/2023 |
10-K
| Annual Report for the period ended December 31, 2022 |
| 03/01/2023 |
4
| Sobel Alan D. (Director) has filed a Form 4 on Cytosorbents Corp|
Txns:
| Gifted 2,000 shares
@ $0
Gifted 2,000 shares
@ $0 |
|
| 02/14/2023 |
SC 13G/A
| AVENIR CORP reports a 5.6% stake in CytoSorbents Corporation |
| 02/09/2023 |
SC 13G/A
| VANGUARD GROUP INC reports a 4.5% stake in CytoSorbents Corp. |
|
|
|